Janney sees upside for Durata Therapeutics, Impax Labs

|About: Durata Therapeutics (DRTX)|By:, SA News Editor

Janney Montgomery starts Durata Therapeutics (DRTX) and Impax Laboratories (IPXL) at Buy.

Price targets: $19 for DRTX and $30 for IPXL.